FMP
Nautilus Biotechnology, Inc.
NAUT
NASDAQ
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
2 USD
-0.01 (-0.5%)
We are unable to load the chart at this time.
Mr. Sujal M. Patel
Healthcare
Biotechnology
NASDAQ
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
0001808805
US63909J1088
63909J108
2701 Eastlake Avenue East
206 333 2001
US
161
Aug 7, 2020
We are unable to load the chart at this time.
We are unable to load the chart at this time.
0001808805
NASDAQ
Biotechnology
Healthcare
63909J108
US63909J1088
US
2
1.04
139.36k
251.13M
-
1.61-3.107
-0.12
-
-
-
-
-3.57
-
https://www.nautilus.bio
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.